Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice

Gut

Volumn 55, Issue 2, 2006, Pages 259-265

  Li, L ^a,c   Yuan, Y Z ^a   Lu, J ^b   Xia, L ^a   Zhu, Y ^a   Zhang, Y P ^a   Qiao, M M ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG; VASOSTATIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER INHIBITION; CELL LINE; CELL PROLIFERATION; CELL STRAIN ECV304; CELL STRUCTURE; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG MECHANISM; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LACZ GENE; MICROVASCULATURE; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; REPORTER GENE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VIRAL GENE THERAPY; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CALRETICULIN; CELL LINE; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 30944439067     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.064980     Document Type: Article

References (38)

1. Yeo CJ. Pancreatic cancer: 1998 update. J Am Coll Surg 1998;187:429-42.
2. Pluda JM, Parkinson DR. Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas. Cancer 1996;78(suppl 3):680-7.
3. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003;3:643-51.
4. Onizuka S, Kawakami S, Taniguchi K, et al. Pancreatic carcinogenesis: apoptosis and angiogenesis. Pancreas 2004;28:317-19.
5. Sauter BV, Martinet O, Zhanq WJ, et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci U S A 2000;97:4802-7.
6. Noro T, Miyake K, Suzuki-Miyake N, et al. Adeno-associated viral vector-mediated expression of endostatin inhibits tumor growth and metastasis in an orthotropic pancreatic cancer model in hamsters. Cancer Res 2004;64:7486-90.
7. Calvo A, Feldman AL, Liburti SK, et al. Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice. Cancer Res 2002;62:3934-8.
8. Dell'Eva R, Pfeffer U, Indraccolo S, et al. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy. Endothelium 2002;9:3-10.
9. Kinoshita S, Hirai R, Yamano T, et al. Angiogenesis inhibitor TNP-470 can suppress hepatocellular carcinoma growth without retarding liver regeneration after partial hepatectomy. Surg Today 2004;34:40-6.
10. Hoshida T, Sunamura M, Duda DG, et al. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor. Pancreas 2002;25:111-21.
11. Heideman DA, van Beusechem VW, Bloemena E, et al. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4. J Gene Med 2004;6:317-27.
12. Martin TA, Parr C, Davies G, et al. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 2003;24:1317-23.
13. Pike SE, Yao L, Setsuda J, et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 1999;94:2461-8.
14. Xiao F, Wei Y, Yang L, et al. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin. Gene Ther 2002;9:1207-13.
15. Pike SE, Yao L, Jones KD, et al. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med 1998;188:2349-56.
16. Parks RJ, Chen L, Anton M, et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 1996;93:13565-70.
17. Park MT, Hwang SJ, Lee GM. Flow cytometric application of helper adenovirus (HAd) containing GFP gene flanked by two parallel loxP sites to evaluation of 293 cre-complementing cell line and monitoring of HAd in Gutless Ad production. Biotechnol Prog 2004;20:913-20.
18. Elsasser HP, Lehr U, Agricola B, et al. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1992;61:295-306.
19. Pan X, Li ZS, Xu GM, et al. Adenovirus-mediated gene transfer in the treatment of pancreatic cancer. Pancreas 2003;26:274-8.
20. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
21. Schmitz V, Wang L, Barajas M, et al. Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice. Gut 2004;53:561-7.
22. Taraboletti G, Giovazzi R. Modelling approaches for angiogenesis. Eur J Cancer 2004;40:881-9.
23. Perrotte P, Matsumoto T, Inoue K, et al. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 1999;5:257-65.
24. Fenton BM, Paoni SF, Lee J, et al. Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements. Br J Cancer 1999;79:464-71.
25. Matsushita A, Onda M, Uchida E, et al. Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer. Int J Cancer 2001;92:434-40.
26. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.
27. Bergers G, Javaherian K, Lo KM, et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999;284:808-12.
28. Garcea G, Lloyd TD, Gescher A, et al. Angiogenesis of gastrointestinal tumours and their metastases-a target for intervention? Eur J Cancer 2004;40:1302-13.
29. Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997;390:404-7.
30. Ramirez PJ, Vickers SM. Current status of gene therapy for pancreatic cancer. Curr Surg 2004;61:84-92.
31. St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003;10:1135-41.
32. Standop J, Schneider MB, Ulrich A, et al. Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer. Dig Dis 2001;19:24-31.
33. Marincola FM, Drucker BJ, Siao DY, et al. The nude mouse as a model for the study of human pancreatic cancer. J Surg Res 1989;47:520-9.
34. Koukourakis MI, Giatromanolaki A, Thorpe PE, et al. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res 2000;60:3088-95.
35. Uzzan B, Nicolas P, Cucherat M, et al. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 2004;64:2941-55.
36. Fenwick SW, Toogood GJ, Lodge JP, et al. The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology 2003;125:716-29.
37. Cianchi F, Cortesini C, Bechi P, et al. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 2001;121:1339-47.
38. Offersen BV, Borre M, Overgaard J. Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 2003;39:881-90.